Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Shares of Medtronic PLC MDT slumped 0.56% to $88.13 Wednesday, on what proved to be an all-around dismal trading session for ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...